About Das Oncocare Private Limited
Data last updated:
Das Oncocare Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC313929. Its GSTIN is 27AAGCD8435K1Z9 (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Bandita Saisudha Patro and Kiran Das.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2022, the company reported a revenue of ₹11.99 Lakh, a growth of 11% compared to the previous year. For the same year it recorded a net loss of ₹32.38 Lakh (net margin -270%) and EBITDA of -₹32.3 Lakh (EBITDA margin -269.3%). Revenue has grown at a compounded annual rate (CAGR) of 457% over three years.
The company is associated with 1 brand: Das Oncocare.
For more details, the company can be reached via its website dasoncocare.com.
Company details
Contact details
Das Oncocare Private Limited's registered office is in Mumbai, Maharashtra. Its website is dasoncocare.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1st Floor Commerz II Cts No 95 4 B 3 & 4 590 Oberoi Garden City Off Western Express, Highway, Mumbai, Maharashtra, India – 400063
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Das Oncocare Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Das Oncocare operates one associated brand: Das Oncocare. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Accessible cancer drugs and OTC health products are provided by Das Oncocare. | dasoncocare.com |
Business activity
The main business activity of Das Oncocare is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Das Oncocare Private Limited, buy the company report.
Financials of Das Oncocare Private Limited
FY 2022 filings availableDas Oncocare Private Limited reported revenue of ₹11.99 Lakh (up 11% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 457% over three years, including 11% growth in the latest year. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹11.99 Lakh | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹32.3 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹32.38 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -269.3% | |||
| Net Profit Margin | -270% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Das Oncocare Private Limited, buy the company report.
Board of directors of Das Oncocare Private Limited
Das Oncocare has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bandita Saisudha Patro | Director | 12 Sep 2018 | 8 Years 1 Months | Current |
| Kiran Das | Director | 12 Sep 2018 | 8 Years 1 Months | Current |
| Jasmine Das | Director | 12 Sep 2018 | 8 Years 1 Months | Current |
| Netajee Patro | Director | 22 Jul 2022 | 4 Years 3 Months | Current |
Peer comparison
Das Oncocare Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avid Oncology Private Limited | ₹12 Lakh (FY 2025) | 0.0% | Haryana, India | |||
| Skin Beyond Borders Private Limited | ₹12 Lakh (FY 2024) | Mumbai, Maharashtra, India | ||||
| Mothercell Biosciences Private Limited | ₹12 Lakh (FY 2025) | -75.0% | Hyderabad, Telangana, India | |||
| Pinkcity Hospitality Private Limited | ₹12 Lakh (FY 2025) | 33.0% | Jaipur, Rajasthan, India | |||
| Sermera Services Private Limited | ₹12 Lakh (FY 2025) | -60.0% | Patna, Bihar, India | |||
| Das Oncocare Private Limitedthis company | ₹11.99 Lakh (FY 2022) | -₹32.38 Lakh | -270% | 11.0% | Mumbai, Maharashtra, India | |
| Remission Life Care Private Limited | ₹11.97 Lakh (FY 2022) | -24.0% | Dhupguri, West Bengal, India | |||
| Mizrat Dental Solutions (OPC) Private Limited | ₹11.97 Lakh (FY 2019) | 376.0% | Mira Road [E, Mumbai, Maharashtra, India | |||
| Mumukshu Healthcare Private Limited | ₹11.94 Lakh (FY 2024) | 63.0% | Thane, Maharashtra, India | |||
| Karthiksharma Reiki Healing Centre (OPC) Private Limited | ₹11.93 Lakh (FY 2024) | 115.0% | Hyderabad, Telangana, India | |||
| Bluefin Pharmaceuticals Private Limited | ₹11.93 Lakh (FY 2020) | 266.0% | Thane, Maharashtra, India |
To see the full peer comparison of Das Oncocare Private Limited, buy the company report.
Auditor
Das Oncocare Private Limited is audited by P R N A M AND ASSOCIATES LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P R N A M AND ASSOCIATES LLP | FY 2022 | 108701W |
Shareholding
The shareholding of Das Oncocare Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Das Oncocare Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Das Oncocare Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Das Oncocare Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Das Oncocare has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCD8435K1Z9 | Maharashtra | Active | 01 Dec 2018 |
To see the full GST registrations and return filing status of Das Oncocare Private Limited, buy the company report.
Recent activity
Das Oncocare Private Limited has 5 board changes on record since 2018: 4 appointments and 1 cessation. The latest: Netajee Patro ceased to be Additional Director on 30 Sep 2022.
Frequently asked questions
Das Oncocare is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 September 2018 (8+ years old) and is registered under CIN U74999MH2018PTC313929.
Das Oncocare has 4 current directors:
- Bandita Saisudha Patro - Director
- Kiran Das - Director
- Jasmine Das - Director
- Netajee Patro - Director
The latest financial statements of Das Oncocare on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Das Oncocare is 27AAGCD8435K1Z9, registered in Maharashtra.
The CIN (Corporate Identification Number) of Das Oncocare is U74999MH2018PTC313929. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Das Oncocare was incorporated on 12 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Das Oncocare by revenue are Avid Oncology Private Limited, Skin Beyond Borders Private Limited, Mothercell Biosciences Private Limited, Pinkcity Hospitality Private Limited, Sermera Services Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Netajee Patro ceased to be Additional Director on 30 Sep 2022. Netajee Patro was appointed as Director on 22 Jul 2022. Bandita Saisudha Patro was appointed as Director on 12 Sep 2018. Das Oncocare has 5 board changes on record in total.
Das Oncocare can be reached through the website dasoncocare.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Das Oncocare is at 1st Floor Commerz II Cts No 95 4 B 3 & 4 590 Oberoi Garden City Off Western Express, Highway, Mumbai, Maharashtra, India – 400063.
Das Oncocare operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
